Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs

The Journal of Immunology(2021)10.4049/jimmunol.2100155Source: DataRank Database

A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs is a research paper published in The Journal of Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.37)OA: bronzeTopics (24)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Jenny Tuyet Tran,Linghang Peng ORCID,Linlin Yang ORCID,Raymond T. Suhandynata ORCID,Melissa Hoffman ORCID

Live enrichment

PubMed:34183368 PMC:PMC8711645 OpenAlex:https://openalex.org/W3173992891

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R37AI059714 and R01AI132317

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: UMI 44462

NIAID NIH HHS

Grant: R01 AI132317

NIAID NIH HHS

Grant: R37 AI059714

FWCI

0.37

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2025

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://journals.aai.org/jimmunol/article-pdf/207/1/344/1501051/ji2100155.pdf

publisherhttps://journals.aai.org/jimmunol/article-pdf/207/1/344/1501051/ji2100155.pdf

publisherhttps://academic.oup.com/jimmunol/article-pdf/207/1/344/61366624/ji2100155.pdf

journalhttps://doi.org/10.4049/jimmunol.2100155

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34183368

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingAdvanced biosensing and bioanalysis techniques

MeSH Terms

Angiotensin-Converting Enzyme 2SARS-CoV-2HumansNeutralization TestsCohort StudiesAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

NeutralizationVirologyNeutralizing antibodyAntibodyTiterCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunoassayMedicineVirusImmunologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Disease

Sustainable Development Goals

SDG 0: Good health and well-being

A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs

FAIR Checklist

Authors (19)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)